The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

This publication has 11 references indexed in Scilit:

• Binding of antipsychotic drugs to human brain receptors
  Life Sciences, 2000
• Efficacy of aripiprazole in psychotic disorders: comparison with haloperidol and placebo
  European Neuropsychopharmacology, 2000
• The Role of Serotonin in Antipsychotic Drug Action
  Neuropsychopharmacology, 1999
• Interactions between neuroleptics and 5-HT 1A ligands in preclinical behavioral models for antipsychotic and extrapyramidal effects
  Psychopharmacology, 1999
• Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPγS binding study
  European Journal of Pharmacology, 1998
• Stimulated [35S]GTPγS binding by 5-HT1A receptor agonists in recombinant cell lines Modulation of apparent efficacy by G-protein activation state
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1997
• Prevention by (±)‐8‐hydroxy‐2‐(di‐npropylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol
  British Journal of Pharmacology, 1996
• Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding
  Psychopharmacology, 1996
• Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors
  Neuropharmacology, 1996
• Reversal of neuroleptic-induced catalepsy by novel aryl-piperazine anxiolytic drugs
  Journal of Pharmacy and Pharmacology, 1988